Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kar-Him Luk"'
Autor:
Kar-Him Luk, Cheuk-Hin Chan, Zhi-Wen Liu, Chun-Wei Jiao, Xiao-Bing Yang, Xiao-Li Dong, Ka-Hing Wong
Publikováno v:
Journal of Functional Foods, Vol 110, Iss , Pp 105832- (2023)
With an increase in aging population, osteoporosis has become one of the major public health issues nowadays, affecting over 200 million people worldwide. Since current medications are associated with various side effects, there is a clear clinical n
Externí odkaz:
https://doaj.org/article/f82d44160fc14647a24db6269bb9fc53
Autor:
Xin Liu, Zhong-Rui Du, Xiong Wang, Kar-Him Luk, Cheuk-Hin Chan, Xu Cao, Qing Zhao, Fang Zhao, Wing-Tak Wong, Ka-Hing Wong, Xiao-Li Dong
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
The role of gut-brain axis in the pathogenesis of Parkinson’s disease (PD) have become a research hotspot, appropriate animal model to study gut-brain axis in PD is yet to be confirmed. Our study employed a classical PD mice model achieved by chron
Externí odkaz:
https://doaj.org/article/2bd8e187ea8a4567bf1e02442df5d6e3
Publikováno v:
Journal of Agricultural and Food Chemistry. 67:2865-2876
Selenium nanoparticles (SeNPs) are recently emerging as promising anticancer agents because of their high bioavailability, low toxicity and remarkable anticancer activities. However, the effects of surface physicochemical properties on the biological
Publikováno v:
Journal of materials chemistry. B. 6(32)
Polysaccharide-protein complex-coated selenium nanoparticles (PTR-SeNPs) system has been rationally designed and identified as a potent bone-formation therapeutic to antagonize osteoporosis. The nanosystem presents high cellular uptake in osteoblast
Autor:
Siu To Cheung, Lizhen He, Zumei Liu, Kar Him Luk, Tianfeng Chen, Keith Kwong Hon Wong, Guanning Huang
Publikováno v:
Biomaterials Science. 6:2508-2517
Selenium nanoparticles (SeNPs) have attracted much interest as potential anticancer nanodrugs. Our previous studies also demonstrated that SeNPs could be developed as carriers of clinically used anticancer drugs to achieve synergistic efficacy. Here,